Caplin Point acquires 10 approved ANDAs to strengthen US injectables, ophthalmic portfolio

Caplin Point primarily serves emerging markets in Latin America and Africa, but has been steadily scaling its footprint in regulated markets through its sterile and oncology platforms.

Leave a Reply

Your email address will not be published. Required fields are marked *